Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Dr Reddy's Laboratories Ltd (DRREDDY) under the Base Case is 1 228.41 INR per share.
Compared with the current market price of 1 377 INR, the stock appears
Overvalued by 11% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Dr Reddy's Laboratories Does
Dr Reddy's Laboratories makes and sells generic medicines, branded prescription drugs, and active pharmaceutical ingredients, or the chemical ingredients used to make medicines. It also develops some specialty products and biosimilars for complex diseases. The company serves patients, doctors, pharmacies, hospitals, and health systems in India and in overseas markets such as the United States, Europe, and other regulated regions.
- Headquarters
- India IN
- Employees
- 27 527
- IPO date
- Jan 1, 1986
Dr Reddy's Laboratories has a narrow economic moat
Hard-to-obtain drug approvals and the work needed to develop complex medicines give Dr Reddy's protection in selected products. Rivals must invest in development, testing and approved manufacturing before they can compete, although ordinary generic medicines face much stronger price competition.
Read the full moat analysis
Revenue & Expenses Breakdown
Dr Reddy's Laboratories Ltd
Earnings Waterfall
Dr Reddy's Laboratories Ltd
What is the Intrinsic Value of one DRREDDY stock?
The intrinsic value for Dr Reddy's Laboratories Ltd (DRREDDY) under the Base Case is 1 228.41 INR.
Is DRREDDY stock undervalued or overvalued?
Compared with the current market price of 1 377 INR, the stock appears Overvalued by 11% .
